NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered GHK-Cu from HK Peptides? Mail in a sample (US only) and let us test it for free.

Test my supply
+5 more ↓
86%
Finnrick rating
#84 of 140 GHK-Cu vendors
43 of 50 classifiable tests passed
customers 4.7★ (31)
methodology · Purity focus
Finnrick analysis · GHK-Cu

HK Peptides' GHK-Cu profile is pulled down by fill volatility more than purity: failures include +505%, +60%, +59% overfills and one 0 mg identity failure. Batch IDs are often absent, so compare rows for repeatability.

methodology →
vendor intelligence report
Vendor Intelligence Report: HK Peptides

Corporate records and homepage evidence point past the Hong Kong branding to a mainland operating trail and a separate manufacturing-facing domain with verification friction. The report maps the HKMS PEP/HPT adjacency, copycat domains, crypto payment rails, and forum impersonation signals.

26 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cuselected
$0.07
86%
50
2
Retatrutide
$1.00
86%
143
3
Tirzepatide
$0.47
82%
132
4
BPC-157
$0.82
75%
22
5
PT-141
-
73%
7
6
Melanotan II
$0.41
68%
12
7
Semaglutide
$0.70
64%
10
8
Cagrilintide
$2.30
60%
11
9
Ipamorelin
$0.81
59%
13
10
Tesamorelin
$1.78
48%
34
11
Sermorelin
$1.57
45%
6
12
TB-500
$1.76
43%
10
13
CJC-1295
$1.90
29%
10
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%16 Jul 2025: 86%4 Aug 2025: 87%4 Aug 2025: 83%4 Aug 2025: 83%18 Sep 2025: 84%21 Oct 2025: 86%23 Oct 2025: 87%6 Nov 2025: 83%17 Nov 2025: 83%6 Dec 2025: 84%17 Dec 2025: 85%17 Dec 2025: 85%17 Dec 2025: 86%6 Jan 2026: 87%6 Jan 2026: 87%19 Jan 2026: 88%19 Jan 2026: 89%19 Jan 2026: 89%19 Jan 2026: 89%26 Jan 2026: 90%26 Jan 2026: 87%26 Jan 2026: 87%2 Feb 2026: 88%2 Feb 2026: 88%9 Feb 2026: 88%9 Feb 2026: 89%11 Feb 2026: 89%11 Feb 2026: 89%18 Feb 2026: 90%18 Feb 2026: 87%20 Feb 2026: 87%22 Feb 2026: 88%22 Feb 2026: 88%26 Feb 2026: 88%2 Mar 2026: 89%12 Mar 2026: 89%12 Mar 2026: 87%18 Mar 2026: 87%18 Mar 2026: 88%29 Mar 2026: 88%28 Apr 2026: 86%28 Apr 2026: 86%5 May 2026: 86%5 May 2026: 87%5 May 2026: 87%20 Jul 2026: 85%3 Aug 2026: 85%3 Aug 2026: 86%15 Sep 2026: 86%24 Sep 2026: 86%29 Sep 2026: current 86%86%85%86%Jul 25Sep 26
Showing GHK-Cu tests only
Free peptide testing

Ordered GHK-Cu from HK Peptides? Mail in a sample (US only) and let us test it for free.

Test my supply
HK Peptides GHK-Cu test history
COA-backed lab tests
1-10 of 50

About HK Peptides test results from Finnrick

HK Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 13 peptides and 460 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible HK Peptides peptides in this dataset are BPC-157 (22 tests) and Melanotan II (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered GHK-Cu from HK Peptides? Mail in a sample (US only) and let us test it for free.

Test my supply